Allero Therapeutics BV
NEXT GENERATION IMMUNOTHERAPIES FOR IMMUNE DISORDERS
4 employees · est. 2019 · Rotterdam, The Netherlands
Alumis
Transforming the lives of patients living with immune-mediated diseases using a precision approach.
249 employees · est. 2021 · South San Francisco, United...
Allero Therapeutics BV is the older company (2019 vs 2021); Alumis is the larger of the two.
Side-by-Side Comparison
| Metric | Allero Therapeutics BV | Alumis |
|---|---|---|
| Founded | ||
| Founded | 2019 older | 2021 |
| Headquarters | ||
| Headquarters | Rotterdam, The Netherlands | South San Francisco, United States |
| Employees | ||
| Employees | 4 | 249 larger |
| Industry | ||
| Industry | Biotechnology, Pharmaceutical | Biotechnology, Health Care, Life Sciences |
| Funding Stage | ||
| Funding Stage | Grant | Series C |
| Total Funding | ||
| Total Funding | $2.57M | $529.00M |
| Funding Rounds | ||
| Funding Rounds | 3 | 3 |
| Services | ||
| Services | Not tracked yet | Development of targeted therapies, Clinical trial management, Proprietary data analytics for precision medicine, Patient resources and expanded access policy |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with immune-mediated diseases, Healthcare providers, Medical researchers, Investors in biotech and pharmaceutical sectors |
| Taxonomy | ||
| Taxonomy | Immunotherapy, Biotech, Therapeutics, Tolerance Induction, Antigen-specific, Autoimmune Diseases, Celiac Diseases, Allergy, COVID-19, ARDS, Food Allergy, Dutch Biotech, SOMIT Technology, Oral Patch Delivery, Immune Disorders | Immune-mediated Diseases, Precision Medicine, Targeted Therapies, Drug Development, Autoimmune Diseases, Immunology, Pharmaceuticals, Integrated Therapy Development, Immunosuppression Alternatives, Patient-centric Solutions, Disease-specific Drug Targeting, Therapeutic Innovation, Healthcare Analytics |
| Website | ||
| Website | allerotherapeutics.com | alumis.com |
About Allero Therapeutics BV
Allero Therapeutics is a Dutch biotech company founded in 2016 that is making significant strides in the development of next generation immunotherapies for immune mediated disorders. The company's proprietary SOMIT (Specific Oromucosal Immunotherapy) technology is at the forefront of this innovation...
About Alumis
Alumis, founded in 2021 and headquartered in the United States, is making strides in the biotechnology, health care, and life sciences industries. The company is committed to transforming the lives of patients with immune-mediated diseases through a precise, targeted approach. By focusing on optimiz...
We will tell you when either one moves
BounceWatch watches Allero Therapeutics BV and Alumis for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Allero Therapeutics BV and Alumis — by email.
Frequently Asked Questions
Compare Allero Therapeutics BV with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Allero Therapeutics BV on 11 Sep 2024, and Alumis on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.